IceCure Medical's Registration Statement Declared Effective by SEC
Ticker: ICCM · Form: EFFECT · Filed: Mar 25, 2026 · CIK: 0001584371
| Field | Detail |
|---|---|
| Company | Icecure Medical Ltd. (ICCM) |
| Form Type | EFFECT |
| Filed Date | Mar 25, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: regulatory-approval, capital-raise, securities-offering
TL;DR
**IceCure Medical's offering is officially greenlit by the SEC, paving the way for potential capital raise.**
AI Summary
The SEC has declared IceCure Medical Ltd.'s registration statement (File No. 333-290046) effective as of March 24, 2026. This means the company can now proceed with its planned offering of securities, likely allowing them to raise capital. For investors, this is a positive step as it indicates the company has met regulatory requirements to potentially fund future growth or operations, which could impact the stock's long-term value.
Why It Matters
This filing signals that IceCure Medical Ltd. has received regulatory approval to move forward with a securities offering, which could provide the company with crucial funding for its operations or expansion plans.
Risk Assessment
Risk Level: low — An EFFECT filing generally indicates a positive regulatory step, reducing uncertainty around a company's ability to raise capital.
Analyst Insight
Investors should view this as a positive regulatory milestone, suggesting the company is on track to secure funding. Further investigation into the details of the underlying registration statement (333-290046) would be prudent to understand the nature and terms of the securities offering.
Key Players & Entities
- IceCure Medical Ltd. (company) — the filer of the EFFECT statement
- SEC (company) — the regulatory body declaring the statement effective
- March 24, 2026 (date) — the effectiveness date of the registration statement
- 333-290046 (dollar_amount) — the file number of the registration statement
FAQ
What is the purpose of an EFFECT filing for IceCure Medical Ltd.?
An EFFECT filing, specifically for IceCure Medical Ltd.'s registration statement (File No. 333-290046), signifies that the SEC has declared the registration statement effective. This allows the company to proceed with its planned offering of securities, enabling them to raise capital from investors.
When did the SEC declare IceCure Medical Ltd.'s registration statement effective?
The SEC declared IceCure Medical Ltd.'s registration statement effective on March 24, 2026, as indicated by the 'Effectiveness Date' in the filing.
What is the CIK number for IceCure Medical Ltd.?
IceCure Medical Ltd.'s CIK (Central Index Key) number is 0001584371, which is used to identify the company in SEC filings.
What is the business address of IceCure Medical Ltd. as listed in the filing?
The business address for IceCure Medical Ltd. is 7 HA'ESHEL ST., POB 3163 CAESAREA, Israel 38900, according to the filing.
What type of industry does IceCure Medical Ltd. operate in, based on its SIC code?
Based on its SIC (Standard Industrial Classification) code 3841, IceCure Medical Ltd. operates in the 'Surgical & Medical Instruments & Apparatus' industry.
Filing Stats: 33 words · 1 min read · ~1 pages · Grade level 9.4 · Accepted 2026-03-25 00:15:09
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-000919.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: March 24, 2026 9:00 A.M. Form: F-3 CIK: Company Name: IceCure Medical Ltd. File Number: 333-290046